Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Laparoscopic allogeneic adipose-derived MSCs for Crohn's inflammatory strictures
2023-507108-30-00Phase 2Completed
- Sponsor
- Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
- Start
- Jul 2023
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of allogeneic adipose tissue-derived mesenchymal stem cells in Crohn's disease, sponsored by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz. Primary endpoints: Proportion and type of complications arising from treatment (adverse reactions) including complications during anesthesia and Complications arising from the treatment administration procedure. Started Jul 2023; status: completed.
02
Drugs
allogeneic adipose tissue-derived mesenchymal stem cells
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2023-507108-30-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-507108-30-00.